94 / 113
94
[72] R. Oostenbrink, K. Spong, A. de Goede-Bolder, J. M. Landgraf, H. Raat, and H. A. Moll, “Parental Reports
of Health-Related Quality Of Life in Young Children with Neurofibromatosis Type 1: Influence of
Condition Specific Determinants,”
J. Pediatr.
, vol. 151, no. 2, pp. 182–186.e2, Aug. 2007.
[73]A. T. Spuijbroek, R. Oostenbrink, J. M. Landgraf, E. Rietveld, A. Goede-Bolder, E. F. Beeck, M. Baar, H.
Raat, and H. A. Moll, “Health-related quality of life in preschool children in five health conditions,”
Qual.
Life Res.
, vol. 20, no. 5, pp. 779–786, Dec. 2010.
[74]A.-M. Vranceanu, V. L. Merker, E. Park, and S. R. Plotkin, “Quality of life among adult patients with
neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: a systematic review of the literature,”
J. Neurooncol.
, Jul. 2013.
[75] P. Wolkenstein, D. Rodriguez, S. Ferkal, H. Gravier, V. Buret, N. Algans, M.-C. Simeoni, and S. Bastuji-
Garin, “Impact of neurofibromatosis 1 upon quality of life in childhood: a cross-sectional study of 79
cases,”
Br. J. Dermatol.
, vol. 160, no. 4, pp. 844–848, Apr. 2009.
[76] K. Nutakki, C. M. Hingtgen, P. Monahan, J. W. Varni, and N. L. Swigonski, “Development of the Adult
PedsQL
TM
Neurofibromatosis Type Feasibility, Reliability and Validity,” 2013.
[77] C. B. Terwee, S. D. M. Bot, M. R. de Boer, D. A. W. M. van der Windt, D. L. Knol, J. Dekker, L. M. Bouter,
and H. C. W. de Vet, “Quality criteria were proposed for measurement properties of health status
questionnaires,”
J. Clin. Epidemiol.
, vol. 60, no. 1, pp. 34–42, Jan. 2007.
[78]A. E. Rubenstein and B. R. Korf,
Neurofibromatose. Handboek voor patiënten, familieleden en
professionele begeleiders
. Leuven-Apeldoorn: Garant-Uitgevers n.v. & NF-kontakt vzw, 1998.
[79] J. Lorenzo, B. Barton, M. T. Acosta, and K. North, “Mental, motor, and language development of toddlers
with neurofibromatosis type 1,”
J. Pediatr.
, vol. 158, no. 4, pp. 660–665, Apr. 2011.
[80] J. Lorenzo, B. Barton, S. S. Arnold, and K. N. North, “Cognitive features that distinguish preschool-age
children with neurofibromatosis type 1 from their peers: a matched case-control study,”
J. Pediatr.
, vol.
163, no. 5, pp. 1479–1483.e1, Nov. 2013.
[81] S. Martin, P. Wolters, A. Baldwin, A. Gillespie, E. Dombi, K. Walker, and B. Widemann, “Social-emotional
functioning of children and adolescents with neurofibromatosis type 1 and plexiform neurofibromas:
relationships with cognitive, disease, and environmental variables,”
J. Pediatr. Psychol.
, vol. 37, no. 7, pp.
713–724, Aug. 2012.
[82]A. Lehtonen, E. Howie, D. Trump, and S. M. Huson, “Behaviour in children with neurofibromatosis type
1: cognition, executive function, attention, emotion, and social competence,”
Dev. Med. Child Neurol.
,
vol. 55, no. 2, pp. 111–125, 2013.
[83] R. B. Noll, J. Reiter-Purtill, B. D. Moore, E. K. Schorry, A. M. Lovell, K. Vannatta, and C. A. Gerhardt,
“Social, emotional, and behavioral functioning of children with NF1,”
Am J Med Genet A
, vol. 143A, no.
19, pp. 2261–73, 2007.
[84] S. Garg, A. Lehtonen, S. M. Huson, R. Emsley, D. Trump, D. G. Evans, and J. Green, “Autism and other
psychiatric comorbidity in neurofibromatosis type 1: evidence from a population-based study,”
Dev.
Med. Child Neurol.
, vol. 55, no. 2, pp. 139–145, Feb. 2013.
[85] K. S. Walsh, J. I. Vélez, P. G. Kardel, D. M. Imas, M. Muenke, R. J. Packer, F. X. Castellanos, and M. T.
Acosta, “Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1,”
Dev. Med. Child Neurol.
, vol. 55, no. 2, pp. 131–138, Feb. 2013.
[86] S. C. Huijbregts and L. M. de Sonneville, “Does cognitive impairment explain behavioral and social
problems of children with neurofibromatosis type 1?,”
Behav Genet
, vol. 41, no. 3, pp. 430–6.
[87]G. Hummelvoll and K. M. Antonsen, “Young adults’ experience of living with neurofibromatosis type 1,”
J. Genet. Couns.
, vol. 22, no. 2, pp. 188–199, Apr. 2013.
[88]M.-J. Descheemaeker, E. Plasschaert, J.-P. Frijns, and E. Legius, “Neuropsychological profile in adults with
neurofibromatosis type 1 compared to a control group: Neuropsychological profile in NF1 adults,”
J.
Intellect. Disabil. Res.
, p. n/a–n/a, Nov. 2012.
[89]N. A. Pride, H. Crawford, J. M. Payne, and K. N. North, “Social functioning in adults with
neurofibromatosis type 1,”
Res. Dev. Disabil.
, vol. 34, no. 10, pp. 3393–3399, Oct. 2013.